Corden Pharma – A Full-Service CDMO

CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products and associated Packaging Services. Through a network of cGMP facilities across Europe and the US organized under five technology platforms – Peptides – Lipids & Carbohydrates – Injectables – Highly Potent & Oncology – Small Molecules – CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products.

<< Peptides >>

• Synthetic Peptide API Production
– Solid-phase, Liquid-phase, Hybrid Synthesis
– cGMP & non-cGMP

<< Lipids & Carbohydrates >>

• Standard and Custom Lipids
(Cationic lipids, PEG-lipids, cholesterol (plant-based), phospholipids, Lipids package solution for LNP, liposome formulation)
• Carbohydrates
(Carbohydrates (i.e. GalNac) for peptides, oligonucleotide drug delivery & formulation)

<< Sterile Injectables >>

• New Development & Commercial Suites for Aseptic Filling with > 60.000 units
per day (Pre-filled Syringes, Liquid or Lyophilized Vials)
• Packaging, Labeling & Logistics
• Sterile Emulsion Technology
• Large Pre-Filled Syringes
• Clinical Trial Services

<< Highly Potent & Oncology >>

• API Development & Commercial Manufacturing
(SafeBridge Category 4, OEL ≤1 ng/m3)
– New Development & Scale-up Capacity for Phase I/II Supply
• Drug Product Development & Manufacturing
– New Development Suite (CTD2) for Mid-scale Oral Dosage (up to 20 kg)
– Sterile Liquid & Lyophilization
– Primary & Secondary Packaging

<< Small Molecules >>

• Development & Commercial Manufacturing
– Intermediates
– APIs & Excipients
– Clinical Supply Phases I-III
• Proprietary & Generic Advanced Intermediates & APIs

Visit > www.cordenpharma.com

Company’s Keywords:

contract development, manufacturing organization, highly potent apis, formulations, drug products, peptides, lipids, carbohydrates, injectables, small molecule apis, excipients, primary, secondary packaging, sterile injectable drug products, aseptic fill, finish